Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 461
Immune Disorders Drugs 195
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 116
Endocrine and Metabolic Disorders Drugs 103
Central Nervous System Drugs 102
Drug Discovery 101
Musculoskeletal Disorders Drugs 92
Pharmaceuticals 89
Clinical Trials 89
Hematological Drugs 83
Leukemia Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 63
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 49
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 25
Bladder Cancer Drugs 24
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

2,373 Results (Page 43 of 119)
- Relevance
  Sort by

Injectable Cytotoxic Drugs Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3829EUR$4,150USD£3,233GBP

Non-Hodgkin Lymphoma Therapeutics - Global Strategic Business Report

 Report
October 2026
176 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

Lymphoma Therapeutics - Global Strategic Business Report

 Report
October 2026
435 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

Hodgkins Lymphoma Treatment - Global Strategic Business Report

 Report
October 2026
127 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

B-Cell Lymphoma Treatment Market - Global Strategic Business Report

 Report
October 2026
392 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market - Global Strategic Business Report

 Report
October 2026
273 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups

 Report
July 2022
60 Pages
France

€9805EUR$11,000USD£8,000GBP

Cough Remedy - Global Strategic Business Report

 Report
October 2026
383 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

Cough Remedies - Global Strategic Business Report

 Report
October 2026
274 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

Beta-thalassemia (B-thal) - Market Insight, Epidemiology And Market Forecast - 2032

 Report
January 2022
196 Pages
Global

From

€6920EUR$7,500USD£5,843GBP

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups

 Report
June 2022
91 Pages
Global

€9805EUR$11,000USD£8,000GBP

Breast Cancer Drugs Market Size, Share & Trends Analysis Report by Therapy (Hormonal Therapy, Targeted Therapy, Chemotherapy, Immunotherapy), Cancer Type, Distribution Channel, and Region with Growth Forecasts, 2025-2033

 Report
December 2025
150 Pages
Global

From

€5490EUR$5,950USD£4,636GBP

Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
January 2023
1469 Pages
Global

From

€4613EUR$5,000USD£3,895GBP

Bile Duct Cancer Market 2024-2028

 Report
October 2024
136 Pages
Global

From

€2307EUR$2,500USD£1,948GBP

Sickle Cell Disease Treatment Market Size, Share & Industry Trends Analysis Report By Treatment (Blood Transfusion, Pharmacotherapy, and Bone Marrow Transplant), By End-Use (Hospitals, Specialty Clinics), By Regional Outlook and Forecast, 2023 - 2030

 Report
August 2023
203 Pages
Global

From

€3321EUR$3,600USD£2,805GBP

Cancer Vaccines Market - Global Forecast 2026-2032

 Report
September 2026
197 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Liver Cirrhosis Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
102 Pages
Global

From

€3500EUR$4,064USD£3,059GBP

Cervical Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
192 Pages
Global

From

€4152EUR$4,500USD£3,506GBP

Human Papillomavirus (HPV) Associated Disorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
180 Pages
Global

From

€4152EUR$4,500USD£3,506GBP

HPV Associated Disorders Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4143EUR$4,490USD£3,498GBP

2,373 Results (Page 43 of 119)
- 1
- 41
- 42
- 43
- 44
- 45

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.